
				
					He founded Sun Pharmaceutical Industries and serves as managing director.

				
				
					The son of a pharmaceuticals distributor, he borrowed $200 from his father to start Sun in 1983 to make psychiatric drugs.

				
				
					The company is the world's fifth largest generics maker and India's most valuable pharma outfit with  2016 revenues of $4.1 billion


				
				
					He grew Sun through a series of shrewd acquisitions, the biggest of which was the purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion in 2014.

				
				
					His fortune has declined two years in a row as Sun's shares fell after the U.S. Food and Drug Administration observed manufacturing lapses at one of its biggest factories in India.

				
		